Cited by 712Venous Thromboembolism Diagnosis and ManagementReproductive Health and ContraceptionBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Hormonal contraception and risk of venous thromboembolism: national follow-up study

Open access

Lidegaard, O., Lokkegaard, E., Svendsen, A. L., Agger, C.·2009·BMJ

DOI 10.1136/bmj.b2890PMC PMC2726928

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To assess the risk of venous thrombosis in current users of different types of hormonal contraception, focusing on regimen, oestrogen dose, type of progestogen, and route of administration. DESIGN: National cohort study. SETTING: Denmark, 1995-2005. PARTICIPANTS: Danish women aged 15-49 with no history of cardiovascular or malignant disease. MAIN OUTCOME MEASURES: Adjusted rate ratios for all first time deep venous thrombosis, portal thrombosis, thrombosis of caval vein, thrombosis of renal vein, unspecified deep vein thrombosis, and pulmonary embolism during the study period. RESULTS: 10.4 million woman years were recorded, 3.3 million woman years in receipt of oral contraceptives. In total, 4213 venous thrombotic events were observed, 2045 in current users of oral contraceptives. The overall absolute risk of venous thrombosis per 10 000 woman years in non-users of oral contraceptives was 3.01 and in current users was 6.29. Compared with non-users of combined oral contraceptives the rate ratio of venous thrombembolism in current users decreased with duration of use (<1 year 4.17, 95% confidence interval 3.73 to 4.66, 1-4 years 2.98, 2.73 to 3.26, and >4 years 2.76, 2.53 to 3.02; P<0.001) and with decreasing dose of oestrogen. Compared with oral contraceptives containing levonorgestrel and with the same dose of oestrogen and length of use, the rate ratio for oral contraceptives with norethisterone was 0.98 (0.71 to 1.37), with norgestimate 1.19 (0.96 to 1.47), with desogestrel 1.82 (1.49 to 2.22), with gestodene 1.86 (1.59 to 2.18), with drospirenone 1.64 (1.27 to 2.10), and with cyproterone 1.88 (1.47 to 2.42). Compared with non-users of oral contraceptives, the rate ratio for venous thromboembolism in users of progestogen only oral contraceptives with levonorgestrel or norethisterone was 0.59 (0.33 to 1.03) or with 75 mug desogestrel was 1.12 (0.36 to 3.49), and for hormone releasing intrauterine devices was 0.90 (0.64 to 1.26). CONCLUSION: The risk of venous thrombosis in current users of combined oral contraceptives decreases with duration of use and decreasing oestrogen dose. For the same dose of oestrogen and the same length of use, oral contraceptives with desogestrel, gestodene, or drospirenone were associated with a significantly higher risk of venous thrombosis than oral contraceptives with levonorgestrel. Progestogen only pills and hormone releasing intrauterine devices were not associated with any increased risk of venous thrombosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/bmj.b2890

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
Jick, H., Jick, S. S., Myers, M. W., Vasilakis‐Scaramozza, C., & Gurewich, V. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91928-7 · Cited by 721
Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study
Spitzer, W. O., Lewis, M. A., Heinemann, L. A. J., Thorogood, M., & MacRae, K. D. (1996) · BMJ · doi:10.1136/bmj.312.7023.83 · Cited by 590
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., Vandenbroucke, J. P., & Buller, H. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91929-5 · Cited by 576
The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation
Dinger, J. C., Heinemann, L. A. J., & Kühl-Habich, D. (2007) · Contraception · doi:10.1016/j.contraception.2006.12.019 · Cited by 472
Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Poulter, N. R., Cl, C., Farley, T., Meirik, O., & Marmot, M. G. (1995) · PubMed · Cited by 404
Oral contraceptives and venous thromboembolism: a five-year national case-control study☆
Lidegaard, Ø., Edström, B., & Kreiner, S. (2002) · Contraception · doi:10.1016/s0010-7824(01)00307-9 · Cited by 332
Population-based study of risk of venous thromboembolism associated with various oral contraceptives
Farmer, R., Lawrenson, R., Thompson, C., Kennedy, J., & Hambleton, I. R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07496-x · Cited by 329
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Farley, T., Meirik, O., Cl, C., Marmot, M. G., & Poulter, N. R. (1995) · PubMed · Cited by 319
Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case‐control study
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89711-6 · Cited by 259
Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis
Jick, H. (2000) · BMJ · doi:10.1136/bmj.321.7270.1190 · Cited by 193

Flagged first, then by citations

Show all 29 references

Sorted by citations

Items 601–700 of 712

Treatment of hyperandrogenism in women with ethinylestradiol and cyproteroneacetate
Mueck, A. O., & on behalf of the global AWARE (Appropriate care for Women with AndRogen Excess) group (2017) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2017.1328170
Early response of selected haemostatic and haematological parameters to physical activity in young women – the potential impact of oral contraceptives
Jastrzebska, M. M., Żyżniewska‐Banaszak, E., Nawrot, M., Marcinowska, Z., Siennicka, A., Chełstowski, K., Stachowiak, P., & Kordaczuk, M. (2017) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/75148
Hormonelle Kontrazeption in der Kinder- und Jugendmedizin
Goeckenjan, M. (2017) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-017-0349-2
PURLs: Which combined OC to prescribe with CV safety in mind?
Lam, Y., Coe, C. L., & Mounsey, A. (2017) · Europe PMC (PubMed Central)
Case 5/2017 - A 28-Year-Old Woman with Cor Pulmonale Due to Pulmonary Hypertension Secondary to Chronic Pulmonary Thromboembolism
Bruno, J. D. A., Nunes, R. A. B., Gutierrez, P. S., & Aiello, V. D. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170148
Hormonal contraception used by adolescents and the risk of tromboembolic disease - topical look
Havlín, M. (2017) · Pediatrie pro praxi · doi:10.36290/ped.2017.058
Female Hormonal Contraception
Plu‐Bureau, G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65736-7
Associations between Plasma 25-Hydroxyvitamin D, Hormonal Contraceptives, and Premenstrual Symptoms
Jarosz, A. C. (2017) · TSpace (University of Toronto)
Estudio del perfil ginecológico de pacientes portadoras de varices esenciales
Rodríguez, M. A. (2018) · doi:10.35376/10324/29493
Efeito do uso de anticoagulante oral sobre o padrão de sangramento associado ao uso do sistema intrauterino liberador de levonorgestrel em mulheres portadoras de trombofilia e/ou com passado de trombose
Braga, G. C. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2017.tde-27072016-154027
Gerinnungsstörungen der Frau
Franz, C., Tchaikovski, V., & Tchaikovski, S. N. (2018) · Frauenheilkunde up2date · doi:10.1055/s-0043-121869
Estudo randomizado sobre o efeito da inserção no pós-parto imediato do implante liberador de etonogestrel no crescimento infantil
do Carmo, L. S. D. M. P. (2018) · doi:10.11606/t.17.2018.tde-23042018-115625
Deep Vein Thrombosis: The Disease
Dekiwadia, D. (2018) · Springer eBooks · doi:10.1007/978-981-13-1108-6_9
COMBINED HORMONAL CONTRACEPTION AND NOT ONLY…
Erofeeva, L. V. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-2-38-44
A 25-Year-Old Woman with a History of Pulmonary Embolism on OCPs Who Desires Contraception
Louis, H. S. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108227469.026
Topical issues in combined oral contraceptives usage
Олеговна, Д. С. (2018) · GYNECOLOGY · doi:10.26442/2079-5696_2018.2.60-63
Kontrazeption bei Frauen mit angeborenen Herzfehlern
Schemm, S. A., Schemm, A., Schwenkhagen, A., & Schaudig, K. T. (2019) · Der Gynäkologe · doi:10.1007/s00129-019-4432-8
Two case-control studies: risk of venous thromboembolism with oral contraceptives
Dunn, N. (2011) · BMJ · doi:10.1136/sbmj.d3139
Thrombophilieabklärung im Hinblick auf östrogenhaltige Kontrazeptiva und Hormonersatztherapie
Pollak, M., & Nagler, M. (2019) · Gynäkologische Endokrinologie · doi:10.1007/s10304-019-0262-y
Thrombophilie und Alter – wann ist eine Hormontherapie in der Postmenopause trotzdem möglich?
Tóth, B., Rank, A., Böttcher, B., & Ludwig, M. Z. (2019) · Gynäkologische Endokrinologie · doi:10.1007/s10304-019-0265-8
Fertility Control in the Cardiac Patient
Briller, J. E., Johnson, M. R., & Roos‐Hesselink, J. W. (2019) · Wiley eBooks · doi:10.1002/9781119409861.ch34
Individual choice of hormonal contraceptive
Kuznetsova, I. V. (2019) · Medical alphabet · doi:10.33667/2078-5631-2019-1-1(376)-6-14
Drospirenon: relativ hohes Thromboserisiko
Gysling, E. (2012) · pharma-kritik · doi:10.37667/pk.2011.859
Presenting research findings
Peacock, J. L., & Peacock, P. J. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198743583.003.0004
Incidence of Deep Vein Thrombosis in the Lower Extremity
de Wet, A. (2020) · The Sydney eScholarship Repository (The University of Sydney)
Determination of Oral Contraceptive pills Effect on Coagulation Profile among Sudanese women in Shendi locality
Khalifa, E. M. (2018)
The Role of Contraception in the Past, Present and Future
Gunardi, E. R., Khusen, D., & Winston, K. (2019) · Journal Of The Indonesian Medical Association · doi:10.47830/jinma-vol.68.8-2018-50
How to advise on safe delivery and best contraception for patients with heart failure
Johnson, M. R., & Cauldwell, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817667-2.00007-4
Injectable Multi-Drug Loaded Hydrogels for Contraception
Nie, L., Zou, P., Sun, M., Han, Y., Ji, C., Zhou, Q., & Suo, J. (2021) · Book Publisher International (a part of SCIENCEDOMAIN International) · doi:10.9734/bpi/nicst/v5/6274d
Drug Utilization Study on Oral Contraceptives provided from Social Security, Buenos Aires-Argentina: Risk and cost analysis according to the type of combination used
Marín, L., Blanco, L., Marin, G., Agüero, S., Pagnotta, M., & Marin, G. H. (2020) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v10i5.4315
Venous and Arterial Risks Associated with Combined Hormonal Contraception
Reid, J. A., & Jensen, J. T. (2021) · Trends in andrology and sexual medicine · doi:10.1007/978-3-030-70932-7_9
Thrombosis and COVID-19 vaccines
Silva, M. A. D. M., Cristino, M. A. B., & Procópio, R. J. (2021) · REVISTA CIÊNCIAS EM SAÚDE · doi:10.21876/rcshci.v11i2.1165
Failure of Lactational Amenorrhea Method (LAM) in Yogyakarta
Johan, R. B., & Mufdlilah (2021) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs211561541
Asesoramiento anticoncepcional para mujeres con trombofilia hereditaria
(2021) · Revista Uruguaya de Medicina Interna · doi:10.26445/06.02.12
Important questions to ask when choosing hormonal contraception. Myths about contraception
Prilepskaya, V. N., & Bostandzhian, L. L. (2021) · GYNECOLOGY · doi:10.26442/20795696.2021.4.201051
Venöse Thromboembolie (VTE): Epidemiologie, Pathophysiologie und natürlicher Verlauf
Kasper, A., & Lindhoff‐Last, E. (2015) · Springer eBooks · doi:10.1007/978-3-642-54676-1_348-1
Hormonal Contraceptives: Progestogen and Thrombotic Risk
Schindler, A. E. (2014) · ISGE series · doi:10.1007/978-3-319-09662-9_8
HOMEOSTASIOLOGICAL STATUS OF WOMEN AGAINST RECEPTION OF COMBINED ORAL CONTRACEPTIVES
Gamyrkina, D. R., & Vorobyova, N. A. (2012) · Экология человека · doi:10.17816/humeco17414
Metabolismo de carboidratos e parâmetros da coagulação sanguínea em novas usuárias não obesas do contraceptivo injetável acetato de medroxiprogesterona de depósito
Melhado‐Kimura, V. (2018) · doi:10.47749/t/unicamp.2018.998786
Kontrazeption
Wiegratz, I. (2009) · Der Gynäkologe · doi:10.1007/s00129-009-2487-7
Venous thromboembolism in women
Abbattista, M. (2022) · doi:10.26481/dis.20220211ma
Evolución del estrógeno en la anticoncepción hormonal combinada: del etinilestradiol al estetrol pasando por el estradiol
Lete, I. (2022) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/j.gine.2022.100755
Renal Diseases
Khattak, H. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108961110.021
A Case of Proteinuria Developing Secondary to Solitary Renal Vein Thrombosis Due to Oral Contraceptive Use
Görünen, A., Sezen, M., Yıldız, A., Oruç, A., Dilek, K., Güllülü, M., Yavuz, M., Boz, S. E. G., & Ersoy, A. (2022) · Turkish Journal of Internal Medicine · doi:10.46310/tjim.1073663
Progestin-Only Oral Contraceptive Pills
Renner, R.-M., & Jensen, J. T. (2011) · Wiley-Blackwell eBooks · doi:10.1002/9780387978598.ch4
Anticoncepción estroprogestágena
Gabriel, R., & Fèvre, A. (2017) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(17)85963-4
Thromboembolies veineuses sous contraceptifs oraux combinés / etat des lieux
(2009) · Bulletin des Médecins Suisses · doi:10.4414/bms.2009.14694
DTB Select: 1 | January 2012
BMJ Publishing Group Ltd (2012) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2011.02.0077
Transition period of estrogen-progestogen hormone therapy
Kuznetsova, I. V. (2019) · Medical alphabet · doi:10.33667/2078-5631-2019-3-25(400)-6-10
In Reply
Wiegratz, I., & Thaler, C. (2011) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2011.0769b
Pharmakologie
Bauersachs, R. M., Kröger, M., Schrör, K., Hohlfeld, T., Spannagl, M., & Hart, C. (2014) · Springer eBooks · doi:10.1007/978-3-642-21496-7_5
Obesity and contraception
Damodaran, S., & Swaminathan, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817919-2.00005-x
Thrombotic Risk of Contraceptives and Other Hormonal Therapies
Konkle, B. A., & Sood, S. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-46202-0.00031-5
Abstracts and Citations
Cooper, W. M., Kaniecki, R. G., & Taylor, F. R. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12643
ภาวะเลอดจบตวเปนลมอดหลอดเลอดกบฮอรโมนคมกำเนดและวคซนปองกนไวรสโคโรนา 2019
Chandeying, V. (2021) · PSU Medical Journal · doi:10.31584/psumj.2021249973
Thrombose et contraception estroprogestative : mise au point du groupe de travail pluridisciplinaire CNGOF-FNCGM-GEHT-SFMV
Chabbert‐Buffet, N., Guigues, B., Trillot, N., Biron, C., Morange, P., Pernod, G., Scheffler, M., Brugere, S., & Hedon, B. (2013) · Sages-Femmes · doi:10.1016/j.sagf.2013.10.001
Hormonal Contraception
Bruni, V., Dei, M., & Pampaloni, F. (2020) · Endocrinology · doi:10.1007/978-3-030-03594-5_7-1
Unidentifiable Thrombophilia
Mantha, S. H., & Soff, G. A. (2016) · Springer eBooks · doi:10.1007/978-3-032-13858-3_35
Faculty Opinions recommendation of A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.
Tapson, V. F. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732885525.793569458
Hormonal Contraception: to Prohibit or Not when Venous Thromboembolic Complications Occur (Literary Review)
Зуховицкая, Е. В., Кажина, М. В., & Курстак, И. А. (2021) · Репродуктивное здоровье Восточная Европа · doi:10.34883/pi.2021.11.2.008
Sexualhormone
Strowitzki, T. (2020) · Springer eBooks · doi:10.1007/978-3-662-62168-4_41
The culture of alcohol and its cost to the NHS
(2010) · Nurse Prescribing · doi:10.12968/npre.2010.8.6.48403
Allgemeine Grundlagen
Zwipp, H., & Rammelt, S. (2014) · Springer eBooks · doi:10.1007/978-3-540-68883-9_1
Isolated portal vein thrombus due to contraceptive low-dose estrogen progestin use
Kon, M., Ishida, H., Yamanaka, Y., Miyauchi, T., & Naganuma, H. (2022) · Journal of Medical Ultrasonics · doi:10.1007/s10396-022-01228-0
Cerebral Venous Sinus Thrombosis Following an mRNA COVID-19 Vaccination and Recent Oral Contraceptive Use
Frommeyer, T. C., Wu, T., Gilbert, M. M., Brittain, G. V., & Fuqua, S. P. (2023) · Life · doi:10.3390/life13020464
A retrospective study on pattern of pulmonary embolism in chestdepartment-Assiut University
El-labody, A., El-Kholy, M. M., Sadek, S. H., & El-morshedy, R. M. (2023) · Journal of Current Medical Research and Practice · doi:10.4103/jcmrp.jcmrp_123_21
Evaluation of Risk Factors of Venous Thromboembolism in Imam Sadiq Teaching Hospital at Babylon City
Almurshedi, I. M. K., Kamil, A. M., & Noaman, A. A. (2022) · Journal of Techniques · doi:10.51173/jt.v4i33.632
Traitements hormonaux de la femme et risque de maladie thromboembolique veineuse
Suchon, P., Plu‐Bureau, G., Gey, L., Harake, S. E., Cohen, S., Élias, A., Morange, P., & Sarlon, G. (2023) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2023.04.009
Complex questions about combined hormonal contraception: A review
Prilepskaya, V. N., & Bostandzhian, L. L. (2023) · GYNECOLOGY · doi:10.26442/20795696.2023.2.202245
Conception and Family Planning - New Aspects [Working Title]
Tsikouras, P., Nikolettos, N., Rath, W. H., & Tempelhoff, F. V. (2023) · Obstetrics and gynecology. · doi:10.5772/intechopen.110909
Drugs, Prescribed: Drug Product Liability
Cooke, C. (2024) · Encyclopedia of Forensic and Legal Medicine · doi:10.1016/b978-0-443-21441-7.00075-3
Hormonale Kontrazeption
Wiegratz, I. (2024) · Springer eBooks · doi:10.1007/978-3-662-65517-7_5
Optimal Pharmacotherapy Strategies for Enhanced Postoperative Recovery in High-Risk Surgeries
Parrish, R. H., & Findley, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-56270-9_29
Management of the Pregnant Woman with Congenital Heart Disease
Park, A., Barbera, K., Rose, C. H., Steury, R., Downing, T. E., Ito, S., & John, A. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-07563-6_98
Clinical Profile of Patients with Peripartum Cardiomyopathy: A Single-center Experience and Review of Literature
Sharma, R., Mishra, P., & Verma, R. (2024) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2497
Female hormonal contraception
Plu‐Bureau, G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00192-8
The effectiveness of combined oral contraceptive pills (COCs) in preventing persistent corpus luteal cysts following oocyte retrieval: a randomized controlled trial
Humart, P., Petyim, S., & Boriboonhirunsan, D. (2025) · Human Fertility · doi:10.1080/14647273.2025.2505634
Development and validation of a contraceptive dispensing protocol for community pharmacists in Qatar: a Delphi study
Baroudi, H. M., Hadi, M. A., Paravattil, B., Khawly, Y. E., & Hajj, M. S. E. (2025) · Journal of Pharmaceutical Policy and Practice · doi:10.1080/20523211.2025.2512186
Challenges in pneumology: pulmonary thromboembolism in young women under hormonal contraception treatment
Sîrbu, D., Trifoi, A., Demenciuc, N., & CHIOTAN, R. A. (2024) · Pneumologia · doi:10.2478/pneum-2025-0013
ENDOMETRIOSIS AND VTE: A REVIEW OF THE EVIDENCE AND PATHOPHYSIOLOGICAL MECHANISMS
Dura, J., Ciechanowicz, J., Ciechanowicz, S., Gutowska, M., Kupidłowski, P., Nowacka, A., Perzanowska, A., Przybylska, A., Tomaszewska, Z., & Zielińska, A. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3489
Coagulation Profiles Among Combined Oral Contraceptive User and Non-User Women Attending at Family Guidance Association of Ethiopia, Jigjiga Medium Clinic: A Comparative Cross-Sectional Study
Getu, F., Tesfaye, A., Mekuria, S., Ayehubizu, L. M., Tahir, B., Roble, A. K., Getu, E., & Walle, M. (2025) · Open Access Journal of Contraception · doi:10.2147/oajc.s544527
Women’s and Transgender Issues in Thrombosis and Hemostasis
Abdulrehman, J., Weyand, A. C., & Shehata, N. (2025) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2025.07.007
RISCO TROMBÓTICO ASSOCIADO À TRANSIÇÃO DO ANTICONCEPCIONAL INJETÁVEL PARA O ORAL: UM RELATO DE CASO SOBRE TROMBOSE VENOSA CEREBRAL
Nery, V. G. C. C. D. A., de Souto, J. R. V., de Carvalho, É. G. M. I., Feitosa, M. E. S., & Loureiro, N. C. F. M. (2025) · Brazilian Medical Students · doi:10.53843/bms.v10i14.1099
Effectiveness of Interventions to Improve Cardiovascular Perturbations in Women with Exercise-Associated Amenorrhea: A Systematic Review
Tegg, N. L., Semmens, J., O’Donnell, E., Myburgh, C., Hyde, A. M., Kennedy, M., & Norris, C. M. (2025) · Women s Health Reports · doi:10.1177/26884844251379434
What should be kept in mind when treating acne with oral contraceptives? Narrative review
Bakalczuk, P., Satora, M., Grunwald, A., Kułak, K., Brzuszkiewicz, K., & Bakalczuk, G. (2025) · Pielegniarstwo XXI wieku / Nursing in the 21st Century · doi:10.12923/pielxxiw-2025-0030
Coagulation Alterations in Single Women using Oral and Injectables Contraceptives in Calabar: Implications for Thromboembolic Risk and Policy Regulation
Okpokam, D. C., George, S. I., Ogidi, N. O., Akpan, E., Nlemadim, O. V., Opara, C. O., Nwaeze, V. C., Obo, E. O., & Emeribe, A. O. (2025) · Trends in Pharmacology and Toxicology · doi:10.21124/tpt.2025.120.126
Oral contraceptive formulation and socio-cognitive performance: a short communication
Mussawar, M., Chenji, S., Bueno, C., & Gordon, J. L. (2025) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253251386245
Case Report: Late-onset cardioembolic stroke following atrial septal defect device closure in a young female
Chitturi, S. S., & Chavan, B. (2025) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2025.101892
Impact of Oral Contraceptive Use for Religio-Cultural Practices on Cerebral Venous Thrombosis Risk in Women: A Systematic Review and Meta-Analysis
Lakshmi Priya., A., Shyam Sundar., S., Padma Priya., A., Kaushik., K., & Dhivya., K. (2025) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2025.v85i10.019
Pregnancy and Contraception
Wander, G., Cauldwell, M., Ferrara, L., & Johnson, M. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-702-08231-3.00023-5
Additional file 1 of A rise in births following contraceptive failure in France between 2010 and 2016: results from the French national perinatal surveys
Bonnet, C., Blondel, B., & Moreau, C. (2021) · Figshare · doi:10.6084/m9.figshare.14253996
Beyond just survival: updates on adult congenital heart disease care
Cao, J., Baker, D., Cordina, R., & Celermajer, D. S. (2025) · European Heart Journal - Valvular and Structural Heart Disease · doi:10.1093/ehjvshd/xwaf004
Post-COVID syndrome. Thromboinflammation and its consequences. Essays and research
(2025) · doi:10.36233/978-5-6052192-3-1
Hormonal Contraceptive Use, Stress Disorders, and Cardiovascular and Thrombotic Risk in Women
Thomas, J. L., Ellis, R. A., AbiKaram, K., Abohashem, S., Dua, A., Lau, E. S., MacDonald, M. J., Miller, K. K., Pineles, S. L., Rosovsky, R. P. G., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.51878
Understanding the Failure of Medical Therapy in PFO-Associated Stroke and the Benefits of Closure: A Narrative Review
Bhagat, R. (2026) · Neurology International · doi:10.3390/neurolint18010011
Morbidity and Mortality Weekly Report: Recommendations and Reports, August 8, 2024 / Vol. 73 / No. RR-3
Curtis, K. M., Nguyen, A. T., Tepper, N. K., Zapata, L. B., Snyder, E. M., Hatfield‐Timajchy, K., Kortsmit, K., Cohen, M. A., & Whiteman, M. K. (2026) · doi:10.15620/cdc/169947
Reproductive Autonomy or Reproductive Control?
Galbraith, E. (2026) · Springer eBooks · doi:10.1007/978-3-032-05946-8_7
Deep Vein Thrombosis Risk Factors: Scoping Review with ☸SAIMSARA
SAIMSARA (2026) · SAIMSARA Journal · doi:10.62487/saimsara05326f98
Interaction des triterpènes avec les membranes synthétiques et l’albumine humaine : application aux progestatifs et corticostéroïdes et à deux structures pentacycliques
Abboud, R. (2016) · theses.fr (ABES) · doi:10.70675/456305d1z35fbz4cdaz9544ze3b7cc4ffd63
Family Planning
Paoletti, A. M., Melis, G. B., Piras, B., Pilloni, M., Zedda, P., Marotto, M. F., Vallerino, V., Melis, A., Taccori, V., Giancane, E., et al. (2026) · Springer eBooks · doi:10.1007/978-3-032-05381-7_75

Authors: Lidegaard, O., Lokkegaard, E., Svendsen, A. L., & Agger, C.
Affiliations: University of Copenhagen (DK)
Venue: BMJ
Publisher: BMJ
Published: 2009-08-13
Volume: 339
Issue: aug13 2
Pages: b2890-b2890
ISSN: 0007-1447 (ISSN-L)
0959-8138
1468-5833
DOI: 10.1136/bmj.b2890
PMC: PMC2726928
OpenAlex: W2027062965
Cited by: 709
References: 29
Citations by year: 2026: 19 · 2025: 39 · 2024: 17 · 2023: 27 · 2022: 35 · 2021: 42 · 2020: 33 · 2019: 31 · 2018: 34 · 2017: 46 · 2016: 32 · 2015: 41 · 2014: 61 · 2013: 74 · 2012: 45
FWCI: 44.51
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
Locations: BMJ (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders: Rigshospitalet
Topics: Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: hormonal contraception, venous thromboembolism, deep vein thrombosis, pulmonary embolism, oral contraceptives, estrogen dose, progestogens, levonorgestrel, norethisterone, desogestrel, gestodene, drospirenone, cyproterone, route of administration, duration of use, thrombosis risk
MeSH terms: Adolescent, Adult, Contraceptives, Oral, Combined, Contraceptives, Oral, Hormonal, Denmark, Epidemiologic Methods, Female, Humans, Middle Aged, Age Distribution, Venous Thromboembolism, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hormonal contraception and risk of venous thromboembolism: national follow-up study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks